Dr. Brian I. Rini
Claim this profileVanderbilt University/Ingram Cancer Center
Area of expertise
Kidney Cancer
Brian I. Rini has run 7 trials for Kidney Cancer. Some of their research focus areas include:
Renal Cell Carcinoma
Brian I. Rini has run 5 trials for Renal Cell Carcinoma. Some of their research focus areas include:
Affiliated Hospitals
Vanderbilt University/Ingram Cancer Center
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Clinical Trials Brian I. Rini is currently running
Immunotherapy + Targeted Therapy
for Genitourinary Cancers
This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving cabozantinib, nivolumab, or ipilimumab alone.
Recruiting
1 award
Phase 2
21 criteria
cfDNA Assay
for Cancer Detection
This is an observational case-control study to train and validate a genome-wide methylome enrichment platform to detect multiple cancer types and to differentiate amongst cancer types. The cancers included in this study are brain, breast, bladder, cervical, colorectal, endometrial, esophageal, gastric, head and neck, hepatobiliary, leukemia, lung, lymphoma, multiple myeloma, ovarian, pancreatic, prostate, renal, sarcoma, and thyroid. These cancers were selected based on their prevalence and mortality to maximize impact on clinical care. Additionally, the ability of the whole-genome methylome enrichment platform to detect minimal residual disease after completion of cancer treatment and to detect relapse prior to clinical presentation will be evaluated in lung cancer. This cancer was selected based on the existing clinical landscape and treatment availability.
Recruiting
1 award
N/A
3 criteria
More about Brian I. Rini
Clinical Trial Related
7 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Brian I. Rini has experience with
- Ipilimumab
- Nivolumab
- Cabozantinib
- Anti-OX40 Antibody PF-04518600
- Axitinib
- Pembrolizumab
Breakdown of trials Brian I. Rini has run
Kidney Cancer
Renal Cell Carcinoma
Cancer
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brian I. Rini specialize in?
Brian I. Rini focuses on Kidney Cancer and Renal Cell Carcinoma. In particular, much of their work with Kidney Cancer has involved Stage IV patients, or patients who are Stage III.
Is Brian I. Rini currently recruiting for clinical trials?
Yes, Brian I. Rini is currently recruiting for 3 clinical trials in Nashville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Brian I. Rini has studied deeply?
Yes, Brian I. Rini has studied treatments such as Ipilimumab, Nivolumab, Cabozantinib.
What is the best way to schedule an appointment with Brian I. Rini?
Apply for one of the trials that Brian I. Rini is conducting.
What is the office address of Brian I. Rini?
The office of Brian I. Rini is located at: Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee 37232 United States. This is the address for their practice at the Vanderbilt University/Ingram Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.